Clin2
NCT07163299Possibly a fitEnrolling by invitation

Cooling artery treatment with magnesium for stroke clot removal

Acute Ischemic Stroke

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests adding a cooled magnesium solution directly into the brain artery during standard clot removal to see if it helps limit brain damage and improve recovery. The magnesium and cooling aim to protect brain tissue while the clot is being taken out.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
42 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old
  • You have had a stroke caused by a clot in a large artery in the front part of the brain
  • Your stroke symptoms started within the last 24 hours and you are able to have a mechanical clot removal procedure
  • Your stroke is moderately severe to severe (NIHSS score of 6 or higher)
  • You were independent before the stroke (able to do daily activities without help)
  • You do not have major bleeding risk, active infection, severe heart/lung/kidney/liver problems, or are pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06760195Not yet recruiting· Early Phase 1
Cooling magnesium with clot removal for stroke

This study tests whether giving a cold magnesium solution directly to the brain during clot removal improves recovery after a stroke. It aims to protect brain cells while the blocked vessel is reopened.

Beijing, Beijing Municipality
NCT06956521Recruiting· Phase 1
Magnesium during clot removal for severe stroke

This trial tests whether giving magnesium directly into the artery during mechanical thrombectomy (a procedure to remove a blood clot from the brain) improves recovery after a severe ischemic stroke. Magnesium may help protect brain cells from further damage after the clot is removed.

Houston, Texas
NCT07137832Recruiting· Phase 3
Testing clot-busting drug during stroke treatment for medium vessel blockages

This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.

Guangzhou, Guangdong
NCT07115940Recruiting
Clot removal after 24 hours for stroke patients

This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.

Chicago, Illinois
NCT07526649Not yet recruiting
Head cooling during clot removal for stroke

This trial tests whether cooling the head during a clot-removal procedure (thrombectomy) can improve recovery after a stroke. It might help reduce brain damage and improve long-term outcomes.

Grafton, Auckland
NCT06155032Recruiting
Clot Removal for Worsening Mild Stroke

This trial tests whether emergency clot removal (endovascular therapy) can help people whose mild stroke gets worse within a week. It's for those who have a blockage in a large brain artery and enough healthy brain tissue to save.

Fuyang, Anhui

Hear when a new Acute Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.